During the past decade, PerCuro Clinical Research Ltd. conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 28 clinical trials were completed, i.e. on average, 96.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 16 clinical trials were completed. i.e. 266.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PerCuro Clinical Research Ltd." #1 sponsor was "Pfizer" with 8 trials, followed by "Celgene" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Shire" with 5 trials sponsored and "Eli Lilly and Company" with 5 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PerCuro Clinical Research Ltd." #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Academic Medical Organization of Southwestern Ontario" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "PerCuro Clinical Research Ltd." are "Crohn's Disease" (12 trials), "Ulcerative Colitis" (8 trials), "Crohn Disease" (5 trials), "Arthritis, Rheumatoid" (3 trials) and "Psoriasis" (3 trials). Many other conditions were trialed in "PerCuro Clinical Research Ltd." in a lesser frequency.

Most popular intervention types in "PerCuro Clinical Research Ltd." are "Drug" (45 trials), "Biological" (4 trials), "Other" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "CP-690,550" (7 trials), "Apremilast 20mg" (3 trials), "Apremilast 30mg" (3 trials) and "Filgotinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "PerCuro Clinical Research Ltd." are 48 trials for "All" genders.

Currently, there are NaN active trials in "PerCuro Clinical Research Ltd.". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 24 completed trials in PerCuro Clinical Research Ltd., undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in PerCuro Clinical Research Ltd., 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".